Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05117190 · ClinicalTrials.gov registry record · NA
Human Composite Facial Allotransplantation
A NA study, sponsored by Methodist Health System.
- Completed
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT05117190: Completed NA study, sponsored by Methodist Health System.
NCT05117190 is a NA study that has completed, run by Methodist Health System. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05117190, a NA study, has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
Allotransplantation of maxillofacial of subject with severe facial deformities due to traumatic events.
Primary Outcome
validated quality-of-life instrument that is used to assess facial impairment and disability after facial paralysis.
Interventions
- PROCEDURE Facial Allotransplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2014-10-21 |
| Est. Completion | 2021-03-18 |
| Phase | NA |
What the finished NCT05117190 record still lists
NCT05117190 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Facial Allotransplantation is the first listed.
NCT05117190 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05117190 about?
NCT05117190 is a clinical study titled "Human Composite Facial Allotransplantation". Allotransplantation of maxillofacial of subject with severe facial deformities due to traumatic events.
What is the current status of trial NCT05117190?
This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2014-10-21. Estimated completion is 2021-03-18.
What interventions are being tested in trial NCT05117190?
The interventions under investigation include: Facial Allotransplantation (PROCEDURE).
Who is sponsoring clinical trial NCT05117190?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05117190's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI